Segment Information (Tables)

12 Months Ended

Dec. 31, 2020

Financial data by reportable segment for the years ended December 31, 2020, 2019 and 2018 is as follows:


	Commercial & Specialty Business		Government Business		IngenioRx	Other		Eliminations		Total
Year ended December 31, 2020
Operating revenue - unaffiliated	$	36,699	$	71,572	10,384	$	2,153	$	—	$	120,808
Operating revenue - affiliated	—		—		11,527	3,904		(15,431)		—
Operating gain (loss)	2,681		2,444		1,361	(126)		—		6,360
Depreciation and amortization of property and equipment	—		—		—	638		—		638
Year ended December 31, 2019
Operating revenue - unaffiliated	$	37,421	$	62,632	2,007	$	1,081	$	—	$	103,141
Operating revenue - affiliated	—		—		3,395	1,212		(4,607)		—
Operating gain (loss)	4,032		2,056		—	(89)		—		5,999
Depreciation and amortization of property and equipment	—		—		—	675		—		675
Year ended December 31, 2018
Operating revenue - unaffiliated	$	35,782	$	55,348	—	$	211	$	—	$	91,341
Operating revenue - affiliated	—		—		—	1,308		(1,308)		—
Operating gain (loss)	3,600		1,928		—	(102)		—		5,426
Depreciation and amortization of property and equipment	—		—		—	652		—		652

Major Product Revenues

The major product revenues for each of the reportable segments for the years ended December 31, 2020, 2019 and 2018 are as follows:


	2020		2019		2018
Commercial & Specialty Business
Managed care products	$	29,815	$	30,311	$	29,012
Managed care services	5,296		5,451		5,218
Dental/Vision products and services	1,231		1,302		1,220
Other	357		357		332
Total Commercial & Specialty Business	36,699		37,421		35,782
Government Business
Managed care products	71,188		62,229		54,889
Managed care services	384		403		459
Total Government Business	71,572		62,632		55,348
IngenioRx
Pharmacy products and services	21,911		5,402		—
Other
Integrated health services	5,787		2,149		1,489
Other	270		144		30
Total Other Business	6,057		2,293		1,519
Eliminations
Eliminations	(15,431)		(4,607)		(1,308)
Total product revenues	$	120,808	$	103,141	$	91,341

Reconciliation Of Reportable Segment Operating Revenues To The Consolidated Statements Of Income

A reconciliation of reportable segments’ operating revenue to the amounts of total revenues included in our consolidated statements of income for the years ended December 31, 2020, 2019 and 2018 is as follows:


	2020		2019		2018
Reportable segments operating revenues	$	120,808	$	103,141	$	91,341
Net investment income	877		1,005		970
Net realized gains (losses) on financial instruments	182		67		(206)
Total revenues	$	121,867	$	104,213	$	92,105

Reconciliation Of Reportable Segment Operating Gain To Income From Continuing Operations Before Income Taxes In The Consolidated Statements Of Income

A reconciliation of reportable segments’ operating gain to income before income tax expense included in our consolidated statements of income for the years ended December 31, 2020, 2019 and 2018 is as follows:


	2020		2019		2018
Reportable segments operating gain	$	6,360	$	5,999	$	5,426
Net investment income	877		1,005		970
Net realized gains (losses) on financial instruments	182		67		(206)
Interest expense	(784)		(746)		(753)
Amortization of other intangible assets	(361)		(338)		(358)
Loss on extinguishment of debt	(36)		(2)		(11)
Income before income tax expense	$	6,238	$	5,985	$	5,068